euchems_admin

REFIT Evaluation of Directive 2009/126/ on Stage II Petrol Vapour Recovery During Refuelling of Motor Vehicles at Service Stations (VOC–II)

The objective of this evaluation is to assess the actual performance of VOC – II compared to initial expectations. Particular emphasis shall be placed on: assessing the effectiveness, efficiency, relevance, coherence and EU added value of the Directive; the detection and assessment of regulatory burden and identifying opportunities for simplification in the Directive. The evaluation shall consider the broader context by taking into account aspects of wider coherence with other legislation addressing VOC and formation of tropospheric ozone. Furthermore, technical developments and relevant legislation in other countries shall be reflected. The scope of the evaluation covers all aspects of VOC – II and assesses its impact since it entered into force and cover the whole European Union.
Website: http://ec.europa.eu/

Consultation on the Preparation of Legislation On Monitoring / Reporting of Heavy-Duty Vehicle Fuel Consumption and CO2 Emissions

The European Commission is launching this consultation to collect the views of stakeholders and citizens with regard to the preparation of legislation on monitoring and reporting of Heavy-Duty Vehicle fuel consumption and CO2 emissions.
Deadline:
28 October 2016
Website
: http://ec.europa.eu/clima/

Public Consultation on the Guidance on the Use of the Benchmark Dose Approach in Risk Assessment

EFSA’s Scientific Committee has launched an open consultation on a draft update of its guidance on the use of the benchmark dose (BMD) approach in risk assessment. This update confirms that the BMD approach is a scientifically more advanced method compared to the NOAEL approach for deriving a Reference Point (RP), and therefore recommends that the BMD approach, and more specifically model averaging, is used for deriving a Reference Point from the critical dose-response data to establish health-based guidance values and margins of exposure.
Deadline: 20 September 2016
Website:
http://www.efsa.europa.eu/

New Layout for EMA Scientific Guidelines

The European Medicines Agency (EMA) has improved its scientific guidelines for human and veterinary medicines on its website. EMA’s scientific guidelines help medicine developers prepare market authorisation applications for human and veterinary medicines. They provide advice to applicants, national competent authorities and other interested parties on the best or most appropriate ways to fulfil the obligations set out in European Union (EU) pharmaceutical legislation.
Source: http://www.ema.europa.eu/ema/

Reporting on the Role of EIT

The European Commission has published the report “Opportunity now: Europe’s mission to innovate “, that looks at how best to position Europe as a global pro-innovation actor. The report highlights that the European Institute of Innovation and Technology (EIT) “offers real added-value” and “inspires highly productive interaction between innovation hubs, stakeholders, start-ups and scale-ups. Thanks to this effective and constructive relationship, access to talent, knowledge and markets and support for new innovative business ventures is continuously fostered by the EIT and its Knowledge and Innovation Communities.” To date, the EIT Community has developed more than 900 business ideas and 200 innovative start-ups in the areas of climate, digitalisation, energy, health and raw materials.
Source: http://eit.europa.eu/